Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
Create a free accountThis page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Esperion Therapeutics, Inc.Security delisted | Sell | $570 | SEC | ||
Esperion Therapeutics, Inc.Security delisted | Sell | $27.7K | SEC | ||
CORCEPT THERAPEUTICS INCListing on record | Sell | $660.6K | SEC | ||
CORCEPT THERAPEUTICS INCListing on record | Sell | $6.9K | SEC | ||
CORCEPT THERAPEUTICS INCListing on record | Sell | $344.9K | SEC | ||
CORCEPT THERAPEUTICS INCListing on record | Sell | $13.2K | SEC | ||
Esperion Therapeutics, Inc.Security delisted | Other | n/a (No price was disclosed in the filing) | SEC | ||
Esperion Therapeutics, Inc.Security delisted | Buy | $3M | conv 45ClusterFirst in 12mo | SEC | |
Esperion Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Esperion Therapeutics, Inc.Security delisted | Other | n/a (No price was disclosed in the filing) | SEC | ||
Esperion Therapeutics, Inc.Security delisted | Buy | $59.6K | conv 41ClusterFirst in 12mo | SEC | |
Esperion Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CORCEPT THERAPEUTICS INCListing on record | Buy | $2.9M | conv 30First in 12mo | SEC | |
CORCEPT THERAPEUTICS INCListing on record | BuyD (derivative) | $111.4K | ClusterFirst in 12mo | SEC | |
CORCEPT THERAPEUTICS INCListing on record | Buy | $3.4M | conv 45ClusterFirst in 12mo | SEC |